IBDEI0YM ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45412,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,45413,0)
 ;;=E10.9^^136^1935^6
 ;;^UTILITY(U,$J,358.3,45413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45413,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,45413,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,45413,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,45414,0)
 ;;=E11.40^^136^1935^15
 ;;^UTILITY(U,$J,358.3,45414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45414,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,45414,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,45414,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,45415,0)
 ;;=E11.620^^136^1935^11
 ;;^UTILITY(U,$J,358.3,45415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45415,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,45415,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,45415,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,45416,0)
 ;;=E11.610^^136^1935^14
 ;;^UTILITY(U,$J,358.3,45416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45416,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,45416,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,45416,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,45417,0)
 ;;=E11.52^^136^1935^17
 ;;^UTILITY(U,$J,358.3,45417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45417,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,45417,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,45417,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,45418,0)
 ;;=E11.51^^136^1935^18
 ;;^UTILITY(U,$J,358.3,45418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45418,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,45418,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,45418,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,45419,0)
 ;;=E11.621^^136^1935^21
 ;;^UTILITY(U,$J,358.3,45419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45419,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,45419,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,45419,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,45420,0)
 ;;=E11.44^^136^1935^8
 ;;^UTILITY(U,$J,358.3,45420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45420,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Amyotrophy
 ;;^UTILITY(U,$J,358.3,45420,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,45420,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,45421,0)
 ;;=E11.59^^136^1935^7
 ;;^UTILITY(U,$J,358.3,45421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45421,1,3,0)
 ;;=3^Diabetes Type 2 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,45421,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,45421,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,45422,0)
 ;;=E11.638^^136^1935^25
 ;;^UTILITY(U,$J,358.3,45422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45422,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,45422,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,45422,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,45423,0)
 ;;=E11.628^^136^1935^27
 ;;^UTILITY(U,$J,358.3,45423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45423,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,45423,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,45423,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,45424,0)
 ;;=E11.630^^136^1935^26
 ;;^UTILITY(U,$J,358.3,45424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45424,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,45424,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,45424,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,45425,0)
 ;;=E11.8^^136^1935^28
 ;;^UTILITY(U,$J,358.3,45425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45425,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,45425,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,45425,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,45426,0)
 ;;=E11.9^^136^1935^29
 ;;^UTILITY(U,$J,358.3,45426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45426,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,45426,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,45426,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,45427,0)
 ;;=E11.36^^136^1935^9
 ;;^UTILITY(U,$J,358.3,45427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45427,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,45427,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,45427,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,45428,0)
 ;;=E11.22^^136^1935^10
 ;;^UTILITY(U,$J,358.3,45428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45428,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,45428,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,45428,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,45429,0)
 ;;=E11.29^^136^1935^12
 ;;^UTILITY(U,$J,358.3,45429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45429,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,45429,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,45429,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,45430,0)
 ;;=E11.21^^136^1935^13
 ;;^UTILITY(U,$J,358.3,45430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45430,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,45430,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,45430,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,45431,0)
 ;;=E11.39^^136^1935^16
 ;;^UTILITY(U,$J,358.3,45431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45431,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,45431,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,45431,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,45432,0)
 ;;=E11.311^^136^1935^20
 ;;^UTILITY(U,$J,358.3,45432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45432,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,45432,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,45432,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,45433,0)
 ;;=E11.319^^136^1935^19
 ;;^UTILITY(U,$J,358.3,45433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45433,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Reinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,45433,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,45433,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,45434,0)
 ;;=Z72.4^^136^1935^30
 ;;^UTILITY(U,$J,358.3,45434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45434,1,3,0)
 ;;=3^Diet & Eating Habits,Inappropriate
 ;;^UTILITY(U,$J,358.3,45434,1,4,0)
 ;;=4^Z72.4
 ;;^UTILITY(U,$J,358.3,45434,2)
 ;;=^5063257
 ;;^UTILITY(U,$J,358.3,45435,0)
 ;;=R68.81^^136^1935^31
 ;;^UTILITY(U,$J,358.3,45435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45435,1,3,0)
 ;;=3^Early Satiety
 ;;^UTILITY(U,$J,358.3,45435,1,4,0)
 ;;=4^R68.81
 ;;^UTILITY(U,$J,358.3,45435,2)
 ;;=^5019554
 ;;^UTILITY(U,$J,358.3,45436,0)
 ;;=E34.9^^136^1935^32
 ;;^UTILITY(U,$J,358.3,45436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45436,1,3,0)
 ;;=3^Endocrine Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,45436,1,4,0)
 ;;=4^E34.9
 ;;^UTILITY(U,$J,358.3,45436,2)
 ;;=^5002777
 ;;^UTILITY(U,$J,358.3,45437,0)
 ;;=R62.7^^136^1935^33
 ;;^UTILITY(U,$J,358.3,45437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45437,1,3,0)
 ;;=3^Failure to Thrive,Adult
 ;;^UTILITY(U,$J,358.3,45437,1,4,0)
 ;;=4^R62.7
 ;;^UTILITY(U,$J,358.3,45437,2)
 ;;=^322019
 ;;^UTILITY(U,$J,358.3,45438,0)
 ;;=R63.3^^136^1935^34
 ;;^UTILITY(U,$J,358.3,45438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45438,1,3,0)
 ;;=3^Feeding Difficulty
 ;;^UTILITY(U,$J,358.3,45438,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,45438,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,45439,0)
 ;;=E87.8^^136^1935^35
 ;;^UTILITY(U,$J,358.3,45439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45439,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,45439,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,45439,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,45440,0)
 ;;=E87.70^^136^1935^36
 ;;^UTILITY(U,$J,358.3,45440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45440,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,45440,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,45440,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,45441,0)
 ;;=R73.01^^136^1935^50
 ;;^UTILITY(U,$J,358.3,45441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45441,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,45441,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,45441,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,45442,0)
 ;;=R73.02^^136^1935^51
 ;;^UTILITY(U,$J,358.3,45442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45442,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,45442,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,45442,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,45443,0)
 ;;=E83.119^^136^1935^37
 ;;^UTILITY(U,$J,358.3,45443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45443,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,45443,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,45443,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,45444,0)
 ;;=E83.52^^136^1935^38
 ;;^UTILITY(U,$J,358.3,45444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45444,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,45444,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,45444,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,45445,0)
 ;;=E11.65^^136^1935^22
 ;;^UTILITY(U,$J,358.3,45445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45445,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,45445,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,45445,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,45446,0)
 ;;=R73.9^^136^1935^39
 ;;^UTILITY(U,$J,358.3,45446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45446,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,45446,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,45446,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,45447,0)
 ;;=E87.5^^136^1935^41
 ;;^UTILITY(U,$J,358.3,45447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45447,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,45447,1,4,0)
 ;;=4^E87.5
